Whistleblowers sue FDA over e-mail monitoring
The Food and Drug Administration is being accused of monitoring the personal e-mails of six employees who had previously reported inappropriate device approvals to Congress and the press.
“Whistleblowers” are protected by law in order to ensure that employees feel comfortable reporting misconduct within an organization. People who raise a red flag are supposed to be free from consequence, and are able to take legal action if they are harassed or treated different based on … Continue Reading
New smartphone ultrasound device is (finally) available
In February 2011, Mobisante got the green light from the U.S. Food and Drug Administration for its mobile, smartphone-powered ultrasound device. It took the medical device startup another eight months to meet the various FDA guidelines, but now its MobiUS SP1 Ultrasound System is finally available for commercial sales starting this month.
The medical device industry is itching to go mobile, but first it has to get the Food and Drug Administration to pick up … Continue Reading
Biogenerics get an unlikely ally — the Bush administration
In February 2011, Mobisante got the green light from the U.S. Food and Drug Administration for its mobile, smartphone-powered ultrasound device. It took the medical device startup another eight months to meet the various FDA guidelines, but now its MobiUS SP1 Ultrasound System is finally available for commercial sales starting this month.
The medical device industry is itching to go mobile, but first it has to get the Food and Drug Administration to pick up … Continue Reading
Why dangerous defibrillator leads could usher in new medical-device regulations
In February 2011, Mobisante got the green light from the U.S. Food and Drug Administration for its mobile, smartphone-powered ultrasound device. It took the medical device startup another eight months to meet the various FDA guidelines, but now its MobiUS SP1 Ultrasound System is finally available for commercial sales starting this month.
The medical device industry is itching to go mobile, but first it has to get the Food and Drug Administration to pick up … Continue Reading
The FDA's big personalized-medicine push
In February 2011, Mobisante got the green light from the U.S. Food and Drug Administration for its mobile, smartphone-powered ultrasound device. It took the medical device startup another eight months to meet the various FDA guidelines, but now its MobiUS SP1 Ultrasound System is finally available for commercial sales starting this month.
The medical device industry is itching to go mobile, but first it has to get the Food and Drug Administration to pick up … Continue Reading
Weekend update: That cold, cold artificial heart, Dendreon-related skulduggery, congressional earmarks, and more
In February 2011, Mobisante got the green light from the U.S. Food and Drug Administration for its mobile, smartphone-powered ultrasound device. It took the medical device startup another eight months to meet the various FDA guidelines, but now its MobiUS SP1 Ultrasound System is finally available for commercial sales starting this month.
The medical device industry is itching to go mobile, but first it has to get the Food and Drug Administration to pick up … Continue Reading
Roundup: Guilt-free stem cells, the trials of Avandia, sponsor research bias, news from ASCO, and more
In February 2011, Mobisante got the green light from the U.S. Food and Drug Administration for its mobile, smartphone-powered ultrasound device. It took the medical device startup another eight months to meet the various FDA guidelines, but now its MobiUS SP1 Ultrasound System is finally available for commercial sales starting this month.
The medical device industry is itching to go mobile, but first it has to get the Food and Drug Administration to pick up … Continue Reading
Patients, CEOs and ideologues vs. evidence-based medicine
In February 2011, Mobisante got the green light from the U.S. Food and Drug Administration for its mobile, smartphone-powered ultrasound device. It took the medical device startup another eight months to meet the various FDA guidelines, but now its MobiUS SP1 Ultrasound System is finally available for commercial sales starting this month.
The medical device industry is itching to go mobile, but first it has to get the Food and Drug Administration to pick up … Continue Reading
Senate approves new drug-safety powers for FDA
In February 2011, Mobisante got the green light from the U.S. Food and Drug Administration for its mobile, smartphone-powered ultrasound device. It took the medical device startup another eight months to meet the various FDA guidelines, but now its MobiUS SP1 Ultrasound System is finally available for commercial sales starting this month.
The medical device industry is itching to go mobile, but first it has to get the Food and Drug Administration to pick up … Continue Reading
Roundup: No-nukes cancer treatment, E. coli vaccines, ovarian-tissue banking, more
In February 2011, Mobisante got the green light from the U.S. Food and Drug Administration for its mobile, smartphone-powered ultrasound device. It took the medical device startup another eight months to meet the various FDA guidelines, but now its MobiUS SP1 Ultrasound System is finally available for commercial sales starting this month.
The medical device industry is itching to go mobile, but first it has to get the Food and Drug Administration to pick up … Continue Reading
"Generic" biologics: Another biotech battle begins
In February 2011, Mobisante got the green light from the U.S. Food and Drug Administration for its mobile, smartphone-powered ultrasound device. It took the medical device startup another eight months to meet the various FDA guidelines, but now its MobiUS SP1 Ultrasound System is finally available for commercial sales starting this month.
The medical device industry is itching to go mobile, but first it has to get the Food and Drug Administration to pick up … Continue Reading
"Generic" biologics: Another biotech battle begins
In February 2011, Mobisante got the green light from the U.S. Food and Drug Administration for its mobile, smartphone-powered ultrasound device. It took the medical device startup another eight months to meet the various FDA guidelines, but now its MobiUS SP1 Ultrasound System is finally available for commercial sales starting this month.
The medical device industry is itching to go mobile, but first it has to get the Food and Drug Administration to pick up … Continue Reading
